Strickler Samantha, Gupta Rohit R, Doucette John T, Kohli-Seth Roopa
Critical Care Medicine Fellow, Mount Sinai Hospital, New York, NY, USA.
Assistant Professor of Surgery, Mount Sinai Hospital, New York, NY, USA.
J Infect Prev. 2018 Jan;19(1):22-28. doi: 10.1177/1757177417720997. Epub 2017 Jul 28.
In the USA, central line associated blood stream infections (CLABSIs) have been designated as 'never events', prompting initiatives towards a 'zero CLABSIs' standard. We propose that there are cascading risk factors predisposing certain patient cohorts to higher CLABSIs rates.
A retrospective review of all CLABSI infections over a 12-month period was undertaken. Risk factors examined included catheter type, insertion site and parenteral nutrition (PN) status. Additional factors analysed included acute kidney injury (AKI), chronic kidney disease (CKD) and hospital-acquired infections (HAIs).
Thirty-four CLABSIs were identified in 33 adult patients (median age = 57 years). Temporary central venous catheters accounted for 12 (35%), peripherally inserted central catheters for five (14.7%), and permanent catheters for 17 CLABSIs (50%); the median duration from insertion was 15 days (interquartile range = 9-26). Among patient factors, immunosuppression and hyperglycaemia were the most common (n = 19, 55%), followed by PN and CKD (n = 17, 50.0%), AKI (n = 16, 47.1%) and HAIs (n = 13, 38.2%). A majority of patients with CLABSIs (n = 20 58.8%) had at least three risk factors.
These findings reflect the complexity of CLABSIs with multiple patient and hospital factors influencing incidence. It suggests the need for further studies to re-calibrate the zero CLABSI model towards one with greater relevance.
在美国,中心静脉导管相关血流感染(CLABSI)已被指定为“绝不允许发生的事件”,促使人们朝着“零CLABSI”标准采取行动。我们提出,存在一系列危险因素使某些患者群体更容易发生较高的CLABSI发生率。
对12个月期间所有CLABSI感染进行回顾性研究。检查的危险因素包括导管类型、插入部位和肠外营养(PN)状态。分析的其他因素包括急性肾损伤(AKI)、慢性肾脏病(CKD)和医院获得性感染(HAI)。
在33例成年患者(中位年龄=57岁)中发现了34例CLABSI。临时中心静脉导管占12例(35%),外周静脉置入中心静脉导管占5例(14.7%),永久性导管占17例CLABSI(50%);插入后的中位持续时间为15天(四分位间距=9-26)。在患者因素中,免疫抑制和高血糖最为常见(n=19,55%),其次是PN和CKD(n=17,50.0%)、AKI(n=16,47.1%)和HAI(n=13,38.2%)。大多数CLABSI患者(n=20,58.8%)至少有三个危险因素。
这些发现反映了CLABSI的复杂性,多种患者和医院因素影响其发生率。这表明需要进一步研究,以便将零CLABSI模型重新校准为更具相关性的模型。